Back to search

Article

The impact of biologic treatment in psoriasis patients on COVID-19 infection: A single-center retrospective study

2023-08-01

Abstract excerpt

Previous studies of whether biologics place psoriasis patients at more severe SARS-CoV-2 infection risk and disease course remains unclear.This single-center retrospective clinical study included patients with psoriasis from December 2022 to April 2023 to compare the rate of COVID-19 infection, duration, and risk of hospitalization and death in patients treated with to without biologics,and to compare the effect o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1b0075eb-1ded-5e43-8b87-cfaf1747378c
DOI
10.21203/rs.3.rs-3208100/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The impact of biologic treatment in psoriasis patients on COVID-19 infection: A single-center retrospective studyDOI 10.21203/rs.3.rs-3208100/v1
Does Biological Therapy Protect against Severe COVID-19?Semantic proximity
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional studySemantic proximity
Aggravation of Psoriasis Following Covid-19: A Study of 105 PatientsSemantic proximity
Covid 19 Infection in Patients with Rheumatic Immune-Mediated Diseases in a Single University Hospital. Matched Case-Control Study and Literature Review.Semantic proximity
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.Semantic proximity
Mortality in Psoriatic Arthritis patients, changes over time and the impact of COVID-19: Results from a multicenter Psoriatic Arthritis Registry (PsART-ID)Semantic proximity
Exploring comorbidities in Colombian psoriasis patients aged 15+: insights from real-world dataSemantic proximity
SARS‐CoV‐2 as possible inducer of viral reactivationsSemantic proximity
Systemic Treatment Strategies for Patients with Psoriasis and Psoriatic Arthritis in the Setting of ANA Positivity or Lupus Spectrum Disease: A Comprehensive Systematic ReviewSemantic proximity
The assessment of the magnitude and associated factors of psoriasisSemantic proximity
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platformSemantic proximity
Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?Semantic proximity
Select a neighboring publication to make it the new centre.